September 19, 2020
“Bellicum Pharmaceuticals (BLCM)… Looking at the consensus breakdown, 2 Buys and no Holds or Sells have been published in the last three months. Therefore, BLCM gets a Moderate Buy consensus rating. Based on the $21.50 average price target, which is… Continue Reading…
Recent Comments